Name: Nyrada (NYR) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

NYR

Nyrada

Pharmaceuticals, Biotechnology & Life Sciences

Drug research and development

Short position

short percentage0.00%

reported shorts16

shares on issue258.682M

Nyrada (ASX:NYR) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 16 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.06% in September 2026. NYR is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads NYR today

Zanger BreakoutWatchScore 8rank 1756 of 1947
CAN SLIMNot a candidate
Minervini Trend TemplateWatchScore 7rank 1633 of 1764
Crowded-Short BreakoutWatchScore 13rank 759 of 1533
Quality compoundersNot a candidate

Prices to 9 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

NYR fundamentals

In the year to 30 Jun 2026, Nyrada (ASX:NYR) recorded revenue of A$2.2M and a net loss after tax of A$6.6M. A year earlier it recorded revenue of A$2.6M and a net loss after tax of A$4.8M. Year-on-year growth: revenue −14.3% (FY). Net margin −298.9%, return on equity −100.0% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 29 Sep 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →